Examining leptospirosis prevalence and risk factors in China

Cigna, the own­er of one of the top phar­ma­cy ben­e­fit man­agers, is su­ing the Fed­er­al Trade Com­mis­sion and Com­mis­sion­er Lina Khan, and ask­ing them to

No­vo Nordisk’s once-week­ly in­sulin has been turned down by the FDA, and the Dan­ish phar­ma like­ly won’t be re­fil­ing un­til next year. The FDA re­jec­tion